Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.

Bibliographic Details
Main Authors:	Bafadhel, M, Davies, L, Calverley, P, Aaron, S, Brightling, C, Pavord, I
Format:	Journal article
Language:	English
Published:	European Respiratory Society 2014

Similar Items

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD
by: Bafadhel, M, et al.
Published: (2016)

Inhaled glucocorticoids and COPD exacerbations.
by: Brightling, C, et al.
Published: (2015)

Prednisolone response in patients with COPD.
by: Pavord, I, et al.
Published: (2004)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
by: Shrimanker, R, et al.
Published: (2017)

Blood eosinophil count and exacerbation risk in patients with COPD.
by: Kerkhof, M, et al.
Published: (2017)

Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population
by: Helen F. Ashdown, et al.
Published: (2021-02-01)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
by: Eltboli, O, et al.
Published: (2014)

Seasonality of eosinophilic and non-eosinophilic exacerbations of COPD
by: Barker, R, et al.
Published: (2017)

Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
by: Moran, AM, et al.
Published: (2020)

Eosinophils in COPD: just another biomarker?
by: Bafadhel, M, et al.
Published: (2017)

Characterising non-eosinophilic COPD
by: Hambleton, K, et al.
Published: (2015)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
by: Siddiqui, S, et al.
Published: (2018)

Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations
by: Djamin, R, et al.
Published: (2019)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
by: Siddiqui SH, et al.
Published: (2018-11-01)

Association between blood eosinophil count and risk of exacerbations in patients with COPD
by: Kerkhof, M, et al.
Published: (2017)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
by: Siva, R, et al.
Published: (2007)

Shall we focus on the eosinophil to guide treatment with systemic corticosteroids during acute exacerbations of COPD?: PRO
by: Camp, J, et al.
Published: (2018)

Prednisolone for COPD exacerbations: time for a rethink
by: Sanjay Ramakrishnan
Published: (2023-09-01)

Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of COPD?: PRO
by: James Camp, et al.
Published: (2018-09-01)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
by: Shrimanker, R, et al.
Published: (2017)

Modelling peripheral blood eosinophils to identify response to budesonide in COPD: a post-hoc analysis
by: Bafadhel, M, et al.
Published: (2017)

Relationship Between Blood Eosinophils and Systemic Corticosteroid Therapy in COPD Exacerbation
by: Gong Y, et al.
Published: (2022-09-01)

Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial.
by: Bafadhel, M, et al.
Published: (2012)

Investigating blood eosinophil count thresholds in patients with COPD
by: Russell, R, et al.
Published: (2018)

Variability of blood eosinophil count and prognosis of COPD exacerbations
by: Sandra Martínez-Gestoso, et al.
Published: (2021-01-01)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
by: Shrimanker, R, et al.
Published: (2017)

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Exacerbation Endpoints
by: Bafadhel, M, et al.
Published: (2018)

Peripheral blood eosinophil drop-to-drop variation in patients with COPD using near patient testing: a small validation study
by: Jeffers, H, et al.
Published: (2017)

COPD exacerbations in general practice: variability in oral prednisolone courses
by: de Vries Marianne, et al.
Published: (2012-01-01)

Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma
by: Moran, A, et al.
Published: (2020)

Evaluation of exacerbations and blood eosinophils in UK and US COPD populations
by: Claus F. Vogelmeier, et al.
Published: (2019-08-01)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
by: Haldar, P, et al.
Published: (2009)

Aspergillus fumigatus during stable state and exacerbations of COPD.
by: Bafadhel, M, et al.
Published: (2014)

Association Between Pathogens Detected Using Quantitative Polymerase Chain Reaction With Airway Inflammation in COPD at Stable State and Exacerbations.
by: Barker, B, et al.
Published: (2015)

Mepolizumab for eosinophilic COPD
by: Sciurba, F, et al.
Published: (2018)

Blood eosinophil levels as a biomarker in COPD
by: Brusselle, G, et al.
Published: (2018)

Copd in the ed: eosinophils, treatment and outcomes, data from the pre-award study
by: Russell, R, et al.
Published: (2016)

The significance of eosinophilic inflammation in COPD
by: Cooper, C, et al.
Published: (2017)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
by: Green, R, et al.
Published: (2002)

Neutrophil-to-lymphocyte ratio, blood eosinophils and COPD exacerbations: a cohort study
by: Jens Ellingsen, et al.
Published: (2021-12-01)